肺炎支原体IgM检测对急性荨麻疹诊治的意义  

Significance of Mycoplasma Pneumoniae IgM Test For the Diagnosis and Treatment of Acute Urticaria

作　　者：黄育涛[1] 蔡幸生[1] 朱勇斌[1] HUANG Yutao CAI Xingsheng ZHU Yongbin(Department of Pediatrics, Jieyang People Hospital, Jieyang 522000, Chin)

机构地区：[1]揭阳市人民医院儿科,广东揭阳522000

出　　处：《临床医学工程》2016年第12期1625-1626,共2页Clinical Medicine & Engineering

摘　　要：目的探讨肺炎支原体IgM检测对急性荨麻疹诊治的临床意义。方法选取2013年1月至2015年12月我院住院的肺炎支原体IgM阳性急性荨麻疹患儿142例的临床资料进行回顾性分析,根据治疗方法的不同分为A组(抗肺炎支原体治疗,72例)和B组(常规治疗,70例),比较两组患儿的疗效及复发率。结果 A组患儿的治疗总有效率为95.83%,B组患儿的治疗总有效率为94.29%,差异无统计学意义(P>0.05)。治疗后1个月、3个月,A组患儿的复发率均显著低于B组,差异均有统计学意义(P<0.05)。结论肺炎支原体IgM阳性急性荨麻疹患儿进行抗支原体治疗,可有效降低复发率,提高临床疗效。Objective To evaluate the clinical significance of the detection of mycoplasma pneumoniae IgM for the diagnosis and treatment of acute urticaria. Methods The clinical data of 142 cases of children with mycoplasma pneumonia IgM-positive acute urticaria admitted to our hospital from January 2013 to December 2015 were retrospectively analyzed. According to the treatment program, all cases were divided into group A （anti-mycoplasma pneumonia treatment, 72 cases） and group B （routine treatment, 70 cases）. The curative effects and recurrence rates of two groups were compared. Results The total effective rate of treatment was 95.83% in group A, and 94.29% in group B, with no statistical difference （P 〉0.05）. 1 month and 3 months after treatment, the recurrence rates of group A were significantly lower than those of group B, with statistical differences （P 〈0.05）. Conclusions Anti-mycoplasma pneumonia treatment for children with mycoplasma pneumonia IgM-positive acute urticaria can effectively reduce the recurrence rate and improve the clinical curative effect.

关 键 词：肺炎支原体 急性荨麻疹 IGM阳性 

分 类 号：R758.24[医药卫生—皮肤病学与性病学]